Health Trials

Relapsed and Refractory Follicular Lymphoma

1

Review clinical trials related to Relapsed and Refractory Follicular Lymphoma. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Orelabrutinib Plus Rituximab Followed by Maintenance With Orelabrutinib for Relapsed and Refractory Follicular Lymphoma(RR FL)

This phase 2 trial studies the efficacy and safety of orelabrutinib plus rituximab followed by maintenance with orelabrutinib for relapsed and refractory follicular lymphoma(RR FL)

Participants needed: 32
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Sun Yat-sen UniversityUpdated: Apr 23, 2026Locations: 3
Eligibility criteria

Histologically confirmed grade 1, 2, or 3A FL; [+6]

Patients who required warfarin or had a history of stroke or intracranial hemorr... [+10]

Read more